c-Fos-driven metabolic switch of α-ketoglutarate orchestrates progression in prostate cancer
Liyan Ao, Zhiqiang Chen, Jingliang Zhang, Qi Wang, Jin Luo, Zhuoran Li, Qilong Jiao, Bobin Ning, Shiyuan Peng, Wenhao Hu, Yuqi Jia, Weimin Ci, Baojun Wang, Zhouhuan Dong, Xu Zhang, Shaoxi Niu · 2026
Read c-Fos-driven metabolic switch of α-ketoglutarate orchestrates progression in prostate cancer by Liyan Ao, Zhiqiang Chen, Jingliang Zhang, Qi Wang, Jin Luo, Zhuoran Li, Qilong Jiao, Bobin Ning, Shiyuan Peng, Wenhao Hu, Yuqi Jia, Weimin Ci, Baojun Wang, Zhouhuan Dong, Xu Zhang, Shaoxi Niu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13273188.txt.
Description
Liyan Ao and a large team traced a metabolic switch in prostate cancer in a 2026 study. Prostate tumors vary greatly, and some change form to resist hormone treatment. The team focused on a molecule called alpha-ketoglutarate, which tumors need for key chemistry.
They found that tumors lean on an enzyme, IDH1, to feed this molecule from citrate. Blocking IDH1 lowered its levels, which steadied a growth signal that then raised c-Fos, a gene control protein. C-Fos switched on another enzyme that makes the molecule from glutamate instead, a backup route. C-Fos also raised genes that push tumors toward a hard to treat nerve like form. The authors suggest blocking these enzymes could weaken tumors and expose them to cell death.
Catalog record
| CREATOR | Liyan Ao, Zhiqiang Chen, Jingliang Zhang, Qi Wang, Jin Luo, Zhuoran Li, Qilong Jiao, Bobin Ning, Shiyuan Peng, Wenhao Hu, Yuqi Jia, Weimin Ci, Baojun Wang, Zhouhuan Dong, Xu Zhang, Shaoxi Niu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 55 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |